Amring Pharmaceuticals Inc. announces name change to Nordic Pharma, Inc. under new Nordic Group, B.V. ownership 03/04/24read more
Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., appoints ophthalmology innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair 02/26/24read more
Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. 01/17/24read more
Nordic Pharma Group B.V. through its subsidiary Amring Pharmaceuticals Inc., completes acquisition of Visant Medical to launch novel therapy for dry eye disease in The United States 12/18/23read more
